|
1
|
Gavin A, Pham JT, Wang D, Brownlow B and
Elbayoumi TA: Layered nanoemulsions as mucoadhesive buccal systems
for controlled delivery of oral cancer therapeutics. Int J
Nanomedicine. 10:1569–1584. 2015.PubMed/NCBI
|
|
2
|
Calixto G, Bernegossi J, Fonseca-Santos B
and Chorilli M: Nanotechnology-based drug delivery systems for
treatment of oral cancer: A review. Int J Nanomedicine.
9:3719–3735. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Strebhardt K and Ullrich A: Paul Ehrlich's
magic bullet concept: 100 years of progress. Nat Rev Cancer.
8:473–480. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deshpande PP, Biswas S and Torchilin VP:
Current trends in the use of liposomes for tumor targeting.
Nanomedicine (London). 8:1509–1528. 2013. View Article : Google Scholar
|
|
5
|
Reddy Chinna P, Chaitanya KS and Rao
Madhusudan Y: A review on bioadhesive buccal drug delivery systems:
Current status of formulation and evaluation methods. DARU.
19:385–403. 2011.PubMed/NCBI
|
|
6
|
Smart JD: Buccal drug delivery. Expert
opin drug deliv. 2:507–517. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sudhakar Y, Kuotsu K and Bandyopadhyay AK:
Buccal bioadhesive drug delivery-a promising option for orally less
efficient drugs. J Control Release. 114:15–40. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mizrahi B and Domb AJ: Mucoadhesive
polymers for delivery of drugs to the oral cavity. Recent Pat Drug
Deliv Formul. 2:108–119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shojaei AH: Buccal mucosa as a route for
systemic drug delivery: a review. J Pharm Pharm Sci. 1:15–30.
1998.PubMed/NCBI
|
|
10
|
Adamczak MI, Hagesaether E, Smistad G and
Hiorth M: An in vitro study of mucoadhesion and biocompatibility of
polymer coated liposomes on HT29-MTX mucus-producing cells. Int J
Pharm. 498:225–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nguyen TX, Huang L, Gauthier M, Yang G and
Wang Q: Recent advances in liposome surface modification for oral
drug delivery. Nanomedicine. 11:1169–1185. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boddupalli BM, Mohammed ZN, Nath RA and
Banji D: Mucoadhesive drug delivery system: An overview. J Adv
Pharm Technol Res. 1:381–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shaikh R, Singh Raj TR, Garland MJ,
Woolfson AD and Donnelly RF: Mucoadhesive drug delivery systems. J
Pharm Bioallied Sci. 3:89–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abruzzo A, Cerchiara T, Bigucci F,
Gallucci MC and Luppi B: Mucoadhesive buccal tablets based on
chitosan/gelatin microparticles for delivery of propranolol
hydrochloride. J Pharm Sci. 104:4365–4372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Steinberg D and Friedman M:
Sustained-release drug delivery of antimicrobials in controlling of
supragingival oral biofilms. Expert Opin Drug Deliv. 14:571–581.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mishra SK, Garud N and Singh R:
Development and evaluation of mucoadhesive buccal patches of
flurbiprofen. Acta Pol Pharm. 68:955–964. 2011.PubMed/NCBI
|
|
17
|
Abbasi MM, Monfaredan A, Hamishehkar H and
Jahanban-Esfahlan R: New formulated ‘DOX-MTX-loaded nanoparticles’
down-regulate HER2 gene expression and improve the clinical outcome
in OSCCs model in rat: The effect of IV and oral modalities. Asian
Pac J Cancer Prev. 15:9355–9360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abbasi MM, Jahanban-Esfahlan R, Monfaredan
A, Seidi K, Hamishehkar H and Khiavi MM: Oral and IV dosages of
doxorubicin-methotrexate loaded-nanoparticles inhibit progression
of oral cancer by down-regulation of matrix Methaloproteinase 2
expression in vivo. Asian Pac J Cancer Prev. 15:10705–10711. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cazzaniga ME, Dionisio MR and Riva F:
Metronomic chemotherapy for advanced breast cancer patients. Cancer
Lett. 400:252–258. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lima Costa SA, Gaspar A, Reis S and Durães
L: Multifunctional nanospheres for co-delivery of methotrexate and
mild hyperthermia to colon cancer cells. Mater Sci Eng C Mater Biol
Appl. 75:1420–1426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Merlano M, Benasso M, Cavallari M, Blengio
F and Rosso M: Chemotherapy in head and neck cancer. Eur J Cancer B
Oral Oncol. 30:283–289. 1994. View Article : Google Scholar
|
|
22
|
Dhanikula RS and Hildgen P: Influence of
molecular architecture of polyether-co-polyester dendrimers on the
encapsulation and release of methotrexate. Biomaterials.
28:3140–3152. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alexa IF, Pastravanu CG, Ignat M and
Popovici E: A comparative study on long-term MTX controlled release
from intercalated nanocomposites for nanomedicine applications.
Colloids Surf B Biointerfaces. 106:135–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Verma DD, Verma S, Blume G and Fahr A:
Particle size of liposomes influences dermal delivery of substances
into skin. Int J Pharm. 258:141–151. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Srisuk P, Thongnopnua P, Raktanonchai U
and Kanokpanont S: Physico-chemical characteristics of
methotrexate-entrapped oleic acid-containing deformable liposomes
for in vitro transepidermal delivery targeting psoriasis treatment.
Int J Pharm. 427:426–434. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sharma M, Malik R, Verma A, Dwivedi P,
Banoth GS, Pandey N, Sarkar J, Mishra PR and Dwivedi AK: Folic acid
conjugated guar gum nanoparticles for targeting methotrexate to
colon cancer. J Biomed Nanotechnol. 9:96–106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Desai KG, Mallery SR, Holpuch AS and
Schwendeman SP: Development and in vitro-in vivo evaluation of
fenretinide-loaded oral mucoadhesive patches for site-specific
chemoprevention of oral cancer. Pharm Res. 28:2599–2609. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Belec L, Tevi-Benissan C, Bianchi A,
Cotigny S, Beumont-Mauviel M, Si-Mohamed A and Malkin JE: In vitro
inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2,
CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by
the spermicide benzalkonium chloride. J Antimicrob Chemother.
46:685–693. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumar R, Verma V, Sharma V, Jain A, Singh
V, Sarswat A, Maikhuri JP, Sharma VL and Gupta G: A precisely
substituted benzopyran targets androgen refractory prostate cancer
cells through selective modulation of estrogen receptors. Toxicol
Appl Pharmacol. 283:187–197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Singh V, Sharma V, Verma V, Pandey D,
Yadav SK, Maikhuri JP and Gupta G: Apigenin manipulates the
ubiquitin-proteasome system to rescue estrogen receptor-β from
degradation and induce apoptosis in prostate cancer cells. Eur J
Nutr. 54:1255–1267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin CC, Yang JS, Chen JT, Fan S, Yu FS,
Yang JL, Lu CC, Kao MC, Huang AC, Lu HF and Chung JG: Berberine
induces apoptosis in human HSC-3 oral cancer cells via simultaneous
activation of the death receptor-mediated and mitochondrial
pathway. Anticancer: res. 27:3371–3378. 2007.PubMed/NCBI
|
|
32
|
Adrian G and Huang L: Entrapment of
proteins in phosphatidylcholine vesicles. Biochemistry.
18:5610–5614. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun B and Chiu DT: Determination of the
encapsulation efficiency of individual vesicles using
single-vesicle photolysis and confocal single-molecule detection.
Analytical chemistry. 77:2770–2776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Akbarzadeh A, Rezaei-Sadabady R, Davaran
S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M and
Nejati-Koshki K: Liposome: Classification, preparation, and
applications. Nanoscale Res Lett. 8:1022013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peppas NA, Moynihan HJ and Lucht LM: The
structure of highly crosslinked poly (2-hydroxyethyl methacrylate)
hydrogels. J Biomed Mater Res. 19:397–411. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peppas NA, Thomas JB and McGinty J:
Molecular aspects of mucoadhesive carrier development for drug
delivery and improved absorption. J Biomater Sci Polym Ed. 20:1–20.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Perioli L, Ambrogi V, Angelici F, Ricci M,
Giovagnoli S, Capuccella M and Rossi C: Development of mucoadhesive
patches for buccal administration of ibuprofen. J Control Release.
99:73–82. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tonglairoum P, Ngawhirunpat T, Rojanarata
T1, Panomsuk S, Kaomongkolgit R and Opanasopit P: Fabrication of
mucoadhesive chitosan coated
polyvinylpyrrolidone/cyclodextrin/clotrimazole sandwich patches for
oral candidiasis. Carbohydr Polym. 132:173–179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Suski JM, Lebiedzinska M, Bonora M, Pinton
P, Duszynski J and Wieckowski MR: Relation between mitochondrial
membrane potential and ROS formation. Methods Mol Biol.
810:183–205. 2012. View Article : Google Scholar : PubMed/NCBI
|
